期刊文献+

叶酸功能化介孔碳纳米球负载阿霉素的细胞靶向传递及可控释放 被引量:4

Folate Functionalized Mesoporous Carbon Nanospheres as Nanocarrier for Targetted Delivery and Controlled Release of Doxorubicin to HeLa Cells
原文传递
导出
摘要 以粒径90 nm的介孔碳纳米球作为靶向传药载体,采用酸化处理改进了材料表面的亲疏水性及在溶液中的分散性,通过壳寡糖功能化,并利用EDC-NHS将叶酸修饰到介孔碳纳米球表面.通过共聚焦激光扫描显微镜及流式细胞仪对实验体系的系统研究,结果表明基于叶酸功能化的介孔碳纳米球能够有效提高负载药物对于HeLa细胞的跨膜转运效率,叶酸阳性表达的HeLa细胞对于叶酸修饰的介孔碳纳米小球的吞噬效率明显高于叶酸阴性表达的MCF-7细胞.对HeLa细胞毒性的定量分析表明叶酸的靶向作用在提高介孔碳纳米球内吞效率的同时,进一步提高了阿霉素对于HeLa细胞的毒性. Ordered mesoporous carbon is a kind of novel carrier for intracellular drug release. There are few reports on the use of mesoporous carbon nanospheres (MCNs) as the transmembrane deliverer in human cancer cells; on the other hand, the particle size of MCNs synthesized by hard templates is usually larger than 100 nm. It is accepted that the optimal size of a transmemhrane delivery vehicle should be less than 100 nm in diameter and the surface should be hydrophilic to circumvent clearance by macrophages, to maximize circulation times and targeting ability. In this work, MCNs with a diameter of ca. 90 nm have been developed as a targeted drug delivery system of an anticancer drug, doxorubicin (DOX). The small MCNs were synthesized using triblock copolymer Pluronic F127 as a template. The MCNs were first treated by acid to improve its dispersion property in an aqueous solution, and then modified by folic acid through EDC-NHS. The structure of the MCNs was well characterized by transmission electron microscopy, small-angle X-ray scattering, nitrogen adsorption/desorption and dynamic light scattering, pH-dependent drug release is successfully achieved due to the supramolecular 7t-n stacking between DOX and the carbonaceous structures. By effective passive and active targeting, MCNs can be readily internalized into HeLa cells, where the carried DOX can be efficiently released in the acidic microenvironment of the tumors for further therapy. The results from confocal laser scanning microscope and flow cytometry demonstrated that the cellular uptake efficiency of MCNs toward HeLa cells was increased through the functionalization with folic acid, and the folate modified MCNs show much higher endocytosis properties toward HeLa cells (folate receptor positive) than toward MCF-7 cells (folate receptor negative). The cytotoxicities toward HeLa cells were studied by MTT method, which indicated that the cytotoxicities of DOX loaded mesoporous carbon nanoparticles was also enhanced due to the introduction of folio acid and targeted delivery, while the cytotoxicities of MCNs show very good biocompatibility toward both HeLa and KB cells.
出处 《化学学报》 SCIE CAS CSCD 北大核心 2013年第1期69-74,共6页 Acta Chimica Sinica
基金 国家自然科学基金(No.20925517) 长春应用化学研究所电分析化学国家重点实验室(No.SKLEAC201101)资助~~
关键词 介孔 纳米材料 癌症 靶向治疗 mesoporous nanoparticle cancer targeted therapy
  • 相关文献

参考文献16

  • 1Morelli, D.; Menard, S.; Colnaghi, M. I.; Balsari, A. Cancer Res. 1996, 56, 2082.
  • 2(a) Vonhoff, D.; Layard, M. W.; Basa, P.; Davis, H. L.; Vonhoff, A. L.; Rozencweig, M.; Muggia, F. M. Ann. Intern. Med. 1979, 91, 710;.
  • 3Byrne, J. D.; Betancourt, T.; Brannon-Peppas, L. Adv. Drug Delivery Rev. 2008, 60, 1615.
  • 4Gabizon, A.; Shmeeda, H.; Barenholz, Y. Clin. Pharmacokinet. 2003, 42, 419.
  • 5(a) Liu, Z.; Fan, A. C.; Rakhra, K.; Sherlock, S.; Goodwin, A.; Chen, X. Y.; Yang, Q. Y.; Felsher, D. W.; Dai, H. J. Angew. Chem., Int. Ed. 2009, 48, 7668;.
  • 6Liu, Z.; Sun, X. M.; Nakayama-Ratchford, N.; Dai, H. J. ACS Nano 2007, 1, 50.
  • 7(a) Vivero-Escoto, J. L.; Slowing, I. I.; Trewyn, B. G.; Lin, V. S. Y. Small 2010, 6, 1952;.
  • 8袁丽,王蓓娣,唐倩倩,张晓鸿,张晓环,杨东,胡建华.介孔二氧化硅纳米粒子应用于可控药物传输系统的若干新进展[J].有机化学,2010,30(5):640-647. 被引量:25
  • 9(a) Kim, T. W.; Chung, P. W.; Slowing, I. I.; Tsunoda, M.; Yeung, E. S.; Lin, V. S. Y. Nano Lett. 2008, 8, 3724;.
  • 10Gu, J. L.; Su, S. S.; Li, Y. S.; He, Q. J.; Shi, J. L. Chem. Commun. 2011, 47, 2101.

二级参考文献2

共引文献24

同被引文献28

  • 1帅怡,郭隽,彭双清,张立实.金属硫蛋白抑制阿霉素引起的心肌细胞凋亡作用研究[J].四川大学学报(医学版),2007,38(4):620-623. 被引量:6
  • 2Norwood W D, Fuqua P A, Mancuso T F. Asbestos-an environmental health hazard[J]. Northwest Med, 1967, 66: 821-828.
  • 3Poonthananiwatkul B, Howard R L, Williamson E M, Lim R H. Cancer patients taking herbal medicines: a review of clinical purposes, associated factors, and perceptions of benefit or harm[J]. J Ethnopharmacol, 2015: 58-66.
  • 4Nygaard I. Balancing innovation and harm[J]. Am J Obstet Gynecol, 2014, 210: 383-384.
  • 5Chen Y C, Kok V C, Chien C H, Horng J T, Tsai J J. Cancer risk in patients aged 30 years and above with type 2 diabetes receiving antidiabetic monotherapy: a cohort study using metformin as the comparator[J]. Ther Clin Risk Manag, 2015, 11: 1315-1323.
  • 6Zou Y, Liu P, Liu C H, Zhi X T. Doxorubicin-loaded mesoporous magnetic nanoparticles to induce apoptosis in breast cancer cells[J]. Biomed Pharmacother, 2015, 69: 355-360.
  • 7Mu B, Liu P, Pu Q. A functional cross linked polymeric nanocapsule with pH-responsive brushes on its inner wall: preparation, characterization and controlled release[J]. React Funct Polym, 2010, 70: 578-584.
  • 8Felber A E, Dufresne M H, Leroux J C. pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates[J]. Adv Drug Deliv Rev, 2012, 64: 979-992.
  • 9Liu J, Sun Z, Deng Y, Zou Y, Li C, Guo X, et al. Highly water-dispersible biocompatible magnetite particles with low cytotoxicity stabilized by citrate groups[J]. Angew Chem Int Ed Engl, 2009, 48: 5875-5879.
  • 10Lu Y, Yin Y D, Mayers B T, Xia Y N. Modifying the surface properties of superparamagnetic iron oxide nanoparticles through a sol-gel approach [J]. Nano Lett, 2002, 2: 183-186.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部